<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38314095</PMID><DateRevised><Year>2024</Year><Month>02</Month><Day>06</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2162-2531</ISSN><JournalIssue CitedMedium="Print"><Volume>35</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Mar</Month><Day>12</Day></PubDate></JournalIssue><Title>Molecular therapy. Nucleic acids</Title><ISOAbbreviation>Mol Ther Nucleic Acids</ISOAbbreviation></Journal><ArticleTitle>MicroRNA-centered theranostics for pulmoprotection in critical COVID-19.</ArticleTitle><Pagination><StartPage>102118</StartPage><MedlinePgn>102118</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">102118</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.omtn.2024.102118</ELocationID><Abstract><AbstractText>Elucidating the pathobiological mechanisms underlying post-acute pulmonary sequelae following SARS-CoV-2 infection is essential for early interventions and patient stratification. Here, we investigated the potential of microRNAs (miRNAs) as theranostic agents for pulmoprotection in critical illness survivors. Multicenter study including 172 ICU survivors. Diffusion impairment was defined as a lung-diffusing capacity for carbon monoxide (D<sub>LCO</sub>) &lt;80% within 12&#xa0;months postdischarge. A disease-associated 16-miRNA panel was quantified in plasma samples collected at ICU admission. Bioinformatic analyses were conducted using KEGG, Reactome, GTEx, and Drug-Gene Interaction databases. The results were validated using an external RNA-seq dataset. A 3-miRNA signature linked to diffusion impairment (miR-27a-3p, miR-93-5p, and miR-199a-5p) was identified using random forest. Levels of miR-93-5p and miR-199a-5p were independently associated with the outcome, improving patient classification provided by the electronic health record. The experimentally validated targets of these miRNAs exhibited enrichment across diverse pathways, with telomere length quantification in an additional set of samples (n&#xa0;= 83) supporting the role of cell senescence in sequelae. Analysis of an external dataset refined the pathobiological fingerprint of pulmonary sequelae. Gene-drug interaction analysis revealed four FDA-approved drugs. Overall, this study advances our understanding of lung recovery in postacute respiratory infections, highlighting the potential of miRNAs and their targets for pulmoprotection.</AbstractText><CopyrightInformation>&#xa9; 2024 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Perez-Pons</LastName><ForeName>Manel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molinero</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ben&#xed;tez</LastName><ForeName>Iv&#xe1;n D</ForeName><Initials>ID</Initials><AffiliationInfo><Affiliation>Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-Hidalgo</LastName><ForeName>Mar&#xed;a C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chatterjee</LastName><ForeName>Shambhabi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B&#xe4;r</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres</LastName><ForeName>Antoni</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Servei de Pneumologia, Hospital Clinic, Universitat de Barcelona, IDIBAPS, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituci&#xf3; Catalana de Recerca i Estudis Avan&#xe7;ats (ICREA), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barb&#xe9;</LastName><ForeName>Ferran</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Gonzalo-Calvo</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>CIBERESUCICOVID Project (COV20/00110, ISCIII)</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Ther Nucleic Acids</MedlineTA><NlmUniqueID>101581621</NlmUniqueID><ISSNLinking>2162-2531</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">MT: Novel therapeutic targets and biomarker development Special Issue</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">microRNA</Keyword><Keyword MajorTopicYN="N">post-COVID syndrome</Keyword><Keyword MajorTopicYN="N">pulmoprotection</Keyword><Keyword MajorTopicYN="N">telomere</Keyword><Keyword MajorTopicYN="N">telomere length</Keyword><Keyword MajorTopicYN="N">theranostics</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>5</Day><Hour>4</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38314095</ArticleId><ArticleId IdType="pmc">PMC10834986</ArticleId><ArticleId IdType="doi">10.1016/j.omtn.2024.102118</ArticleId><ArticleId IdType="pii">S2162-2531(24)00005-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schlemmer F., Valentin S., Boyer L., Guillaumot A., Chabot F., Dupin C., Le Guen P., Lorillon G., Bergeron A., Basille D., et al. Respiratory recovery trajectories after severe-to-critical COVID-19: a 1-year prospective multicentre study. Eur. Respir. J. 2023;61</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10066566</ArticleId><ArticleId IdType="pubmed">36669777</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez J., de Batlle J., Ben&#xed;tez I.D., Torres G., Santisteve S., Targa A.D.S., Gort-Paniello C., Moncus&#xed;-Moix A., Aguil&#xe0; M., Seck F., et al. Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients. Arch. Bronconeumol. 2023;59:205&#x2013;215.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9824938</ArticleId><ArticleId IdType="pubmed">36690515</ArticleId></ArticleIdList></Reference><Reference><Citation>Saunders C., Sperling S., Bendstrup E. A new paradigm is needed to explain long COVID. Lancet Respir. Med. 2023;11:e12&#x2013;e13.</Citation><ArticleIdList><ArticleId IdType="pubmed">36620963</ArticleId></ArticleIdList></Reference><Reference><Citation>Khorkova O., Stahl J., Joji A., Volmar C.H., Wahlestedt C. Amplifying gene expression with RNA-targeted therapeutics. Nat. Rev. Drug Discov. 2023;22:539&#x2013;561.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10227815</ArticleId><ArticleId IdType="pubmed">37253858</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomou T., Mori M.A., Dreyfuss J.M., Konishi M., Sakaguchi M., Wolfrum C., Rao T.N., Winnay J.N., Garcia-Martin R., Grinspoon S.K., et al. Adipose-derived circulating miRNAs regulate gene expression in other tissues. Nature. 2017;542:450&#x2013;455.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5330251</ArticleId><ArticleId IdType="pubmed">28199304</ArticleId></ArticleIdList></Reference><Reference><Citation>Eckhardt C.M., Gambazza S., Bloomquist T.R., De Hoff P., Vuppala A., Vokonas P.S., Litonjua A.A., Sparrow D., Parvez F., Laurent L.C., et al. Extracellular Vesicle-Encapsulated microRNAs as Novel Biomarkers of Lung Health. Am. J. Respir. Crit. Care Med. 2023;207:50&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9952856</ArticleId><ArticleId IdType="pubmed">35943330</ArticleId></ArticleIdList></Reference><Reference><Citation>Karagkouni D., Paraskevopoulou M.D., Chatzopoulos S., Vlachos I.S., Tastsoglou S., Kanellos I., Papadimitriou D., Kavakiotis I., Maniou S., Skoufos G., et al. DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA&#x2013;gene interactions. Nucleic Acids Res. 2018;46:D239&#x2013;D245.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5753203</ArticleId><ArticleId IdType="pubmed">29156006</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D., Gable A.L., Nastou K.C., Lyon D., Kirsch R., Pyysalo S., Doncheva N.T., Legeay M., Fang T., Bork P., et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2021;49:D605&#x2013;D612.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7779004</ArticleId><ArticleId IdType="pubmed">33237311</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Hidalgo M.C., Pel&#xe1;ez R., Gonz&#xe1;lez J., Santisteve S., Ben&#xed;tez I.D., Molinero M., Perez-Pons M., Belmonte T., Torres G., Moncus&#xed;-Moix A., et al. Genome-wide transcriptional profiling of pulmonary functional sequelae in ARDS- secondary to SARS-CoV-2 infection. Biomed. Pharmacother. 2022;154</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9424524</ArticleId><ArticleId IdType="pubmed">36058144</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee S., de Gonzalo-Calvo D., Derda A.A., Schimmel K., Sonnenschein K., Bavendiek U., Bauersachs J., B&#xe4;r C., Thum T. Leukocyte telomere length correlates with hypertrophic cardiomyopathy severity. Sci. Rep. 2018;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6060137</ArticleId><ArticleId IdType="pubmed">30046139</ArticleId></ArticleIdList></Reference><Reference><Citation>Lonsdale J., Thomas J., Salvatore M., Phillips R., Lo E., Shad S., Hasz R., Walters G., Garcia F., Young N., et al. The Genotype-Tissue Expression (GTEx) project. Nat. Genet. 2013;45:580&#x2013;585.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4010069</ArticleId><ArticleId IdType="pubmed">23715323</ArticleId></ArticleIdList></Reference><Reference><Citation>Freshour S.L., Kiwala S., Cotto K.C., Coffman A.C., McMichael J.F., Song J.J., Griffith M., Griffith O.L., Wagner A.H. Integration of the Drug&#x2013;Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts. Nucleic Acids Res. 2021;49:D1144&#x2013;D1151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7778926</ArticleId><ArticleId IdType="pubmed">33237278</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres A., Motos A., Ceccato A., Bermejo-Martin J., de Gonzalo-Calvo D., P&#xe9;rez R., Barroso M., Pascual I.Z., Gonzalez J., Fern&#xe1;ndez-Barat L., et al. Methodology of a Large Multicenter Observational Study of Patients with COVID-19 in Spanish Intensive Care Units. Arch. Bronconeumol. 2022;58:22&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9012512</ArticleId><ArticleId IdType="pubmed">35491287</ArticleId></ArticleIdList></Reference><Reference><Citation>de Gonzalo-Calvo D., Molinero M., Ben&#xed;tez I.D., Perez-Pons M., Garc&#xed;a-Mateo N., Ortega A., Postigo T., Garc&#xed;a-Hidalgo M.C., Belmonte T., Rodr&#xed;guez-Mu&#xf1;oz C., et al. A blood microRNA classifier for the prediction of ICU mortality in COVID-19 patients: a multicenter validation study. Respir. Res. 2023;24:159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10276486</ArticleId><ArticleId IdType="pubmed">37328754</ArticleId></ArticleIdList></Reference><Reference><Citation>de Gonzalo-Calvo D., Ben&#xed;tez I.D., Pinilla L., Carratal&#xe1; A., Moncus&#xed;-Moix A., Gort-Paniello C., Molinero M., Gonz&#xe1;lez J., Torres G., Bernal M., et al. Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patients. Transl. Res. 2021;236:147&#x2013;159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8149473</ArticleId><ArticleId IdType="pubmed">34048985</ArticleId></ArticleIdList></Reference><Reference><Citation>Cawthon R.M. Telomere measurement by quantitative PCR. Nucleic Acids Res. 2002;30:e47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC115301</ArticleId><ArticleId IdType="pubmed">12000852</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Delgado B., Yanowsky K., Inglada-Perez L., Domingo S., Urioste M., Osorio A., Benitez J. Genetic anticipation is associated with telomere shortening in hereditary breast cancer. PLoS Genet. 2011;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3145621</ArticleId><ArticleId IdType="pubmed">21829373</ArticleId></ArticleIdList></Reference><Reference><Citation>Willeit P., Willeit J., Mayr A., Weger S., Oberhollenzer F., Brandst&#xe4;tter A., Kronenberg F., Kiechl S. Telomere length and risk of incident cancer and cancer mortality. JAMA. 2010;304:69&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">20606151</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>